SELEGILINE 5 MG
SELEGILINE HYDROCHLORIDE : 5 MG · DIN 02230641 · AA PHARMA INC
Health Canada status: MARKETED
What is SELEGILINE?
SELEGILINE 5 MG contains SELEGILINE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02230641, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Aug-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SELEGILINE used for?
SELEGILINE (selegiline hydrochloride) may be of value: – as an adjunct to levodopa (with or without a decarboxylase inhibitor) in the management of the signs and symptoms of Parkinson’s Disease. – in newly diagnosed patients before symptoms begin to affect the patient’s social or professional life, at which time more efficacious treatment becomes necessary.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02230641 |
|---|---|
| Brand name | SELEGILINE |
| Generic / active ingredient | SELEGILINE HYDROCHLORIDE : 5 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04BD01 SELEGILINE |
| AHFS class | 28:36.32 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Aug-2021 |
| Original market date | 1997-02-13 00:00:00 |
How is it administered?
10 mg per day administered as divided doses of 5 mg each taken at breakfast and lunch. Do not exceed 10 mg/day. Levodopa dose may need reduction by 10-30% when starting adjunctive therapy.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature 15°C to 30°C. Protect from light.
How is it supplied?
Bottles of 100
Contraindications
Hypersensitivity; extrapyramidal disorders (e.g., excessive tremor, tardive dyskinesia); severe psychosis; profound dementia; active peptic ulcer; combination with meperidine or other opioids.
Warnings and precautions
Do not exceed 10 mg/day to maintain MAO-B selectivity. Risk of hypertensive crisis (cheese reaction) at higher doses. Serious CNS events when combined with TCAs or SSRIs.
What can be used instead?
Other Canadian products sharing ATC code N04BD01 SELEGILINE. 1 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DOM-SELEGILINE | 5 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02238340 |
| ELDEPRYL - 5MG TAB | 5 MG | TABLET | DRAXIS HEALTH INC. | CANCELLED POST MARKET | DIN 02123312 |
| ELDEPRYL TAB 5MG | 5 MG | TABLET | DEPRENYL RESEARCH LTD. | CANCELLED POST MARKET | DIN 00791091 |
| MED SELEGILINE | 5 MG | TABLET | MEDICAN PHARMA INCORPORATED | CANCELLED POST MARKET | DIN 02237289 |
| MYLAN-SELEGILINE | 5 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02231036 |
| NU-SELEGILINE | 5 MG | TABLET | NU-PHARM INC | CANCELLED POST MARKET | DIN 02230717 |
| PMS-SELEGILINE | 5 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02238102 |
| SELEGILINE | 5 MG | TABLET | PHARMEL INC | CANCELLED POST MARKET | DIN 02238319 |
| SELEGILINE-5 | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02231479 |
| TEVA-SELEGILINE | 5 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02068087 |
Who else supplies SELEGILINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SELEGILINE appears in 11 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.